AAV9-Mediated PTEN Gene Therapy Rescues Hepatic Pathology and Neuroanatomical Abnormalities in a Murine Model of PTEN Hamartoma Tumour Syndrome
Pharmaceutics · 27.07.2026 · 18 (8) · 922
DOI: 10.3390/pharmaceutics18080922 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 27.07.2026. Verfasst von Ceren Erdem und 6 weiteren Autor:innen. Beteiligte Einrichtung: Simons Initiative for the Developing Brain, Centre for Discovery Brain Sciences, University of Edinburgh, Edinburgh EH8 9XD, UK. Die Arbeit nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: scholarship from the Republic of Türkiye Minister of National Education (YLSY scholarship)., Rettco Inc., Republic of Türkiye Minister of National Education.
Abstract (Originalsprache)
Background/Objectives: PTEN Hamartoma Tumour Syndrome (PHTS) is a rare inherited disorder caused by germline PTEN mutations, presenting with cancer predisposition and neurodevelopmental abnormalities, including macrocephaly. PTEN functions as a tumour suppressor by regulating the PI3K/AKT/mTOR pathway and contributes to cellular adhesion, migration, and genomic stability. As no curative therapy exists, gene therapy represents a promising avenue to correct the underlying genetic defect.
Methods
In this study we evaluated the therapeutic potential of AAV9-mediated PTEN gene delivery in a PtenΔ5/+ mouse model, which is predominantly characterized by progressive lymphoid hyperplasia leading to lymph node tumour development, as well as hepatic focal lesions and macrocephaly.
Results
Systemic vector delivery did not improve lymph node enlargement which represents the predominant disease phenotype in the PtenΔ5/+ mice at the doses tested, due to restricted vector biodistribution, but it did effectively rescue the hepatic lesions, including steatosis and steatohepatitis-like changes. Mechanistically, AAV-mediated PTEN expression significantly reduced elevated p-AKT levels, indicating attenuated hyperactivation of the PI3K/AKT/mTOR pathway. Additionally, intracranial delivery of the same vector in PtenΔ5/+ mouse neonates ameliorated macrocephaly without apparent adverse effects.
Conclusions
These findings highlight the therapeutic potential of AAV9-mediated PTEN gene therapy in PHTS, particularly for hepatic and neuroanatomical manifestations. Optimization of vector biodistribution and transduction efficiency will be critical for clinical translation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Simons Initiative for the Developing Brain, Centre for Discovery Brain Sciences, University of Edinburgh, Edinburgh EH8 9XD, UK.
- Department of Medical Biology, Faculty of Medicine, Pamukkale University, Denizli 20070, Türkiye.
- Department of Histology, Faculty of Medicine, Tanta University, Tanta 31527, Egypt.
- Centre for Inflammation Research, Institute for Regeneration and Repair, University of Edinburgh, Edinburgh EH16 4UU, UK.
- Centre for Systems Health and Integrated Metabolic Research (SHiMR), Department of Biosciences, School of Science and Technology, Nottingham Trent University, Nottingham NG11 8NS, UK.
ORCID-Profile: Ceren Erdem, Noha Bahey, Jim Selfridge, Timothy Kendall
Förderung
- scholarship from the Republic of Türkiye Minister of National Education (YLSY scholarship).
- Rettco Inc.
- Republic of Türkiye Minister of National Education
Zitieren
APA
Erdem, C., Thomson, S., Bahey, N., Selfridge, J., Kendall, T., Cobb, S., & Gadalla, K. (2026). AAV9-Mediated PTEN Gene Therapy Rescues Hepatic Pathology and Neuroanatomical Abnormalities in a Murine Model of PTEN Hamartoma Tumour Syndrome. Pharmaceutics, 18(8), 922. https://doi.org/10.3390/pharmaceutics18080922
Vancouver
Erdem C, Thomson S, Bahey N, Selfridge J, Kendall T, Cobb S, et al. AAV9-Mediated PTEN Gene Therapy Rescues Hepatic Pathology and Neuroanatomical Abnormalities in a Murine Model of PTEN Hamartoma Tumour Syndrome. Pharmaceutics. 2026;18(8):922. doi:10.3390/pharmaceutics18080922
BibTeX
@article{Erdem2026,
author = {Erdem, Ceren and Thomson, Sophie and Bahey, Noha and Selfridge, Jim and Kendall, Timothy and Cobb, Stuart and Gadalla, Kamal},
title = {AAV9-Mediated PTEN Gene Therapy Rescues Hepatic Pathology and Neuroanatomical Abnormalities in a Murine Model of PTEN Hamartoma Tumour Syndrome},
journal = {Pharmaceutics},
year = {2026},
volume = {18},
number = {8},
pages = {922},
doi = {10.3390/pharmaceutics18080922}
}
EUVIMED